Hexagon Capital Partners’s Cytosorbents Corp CTSO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,333
| Closed | -$3.33K | – | 446 |
|
|
2025
Q1 | $3.33K | Hold |
3,333
| – | – | ﹤0.01% | 1279 |
|
|
2024
Q4 | $3.03K | Hold |
3,333
| – | – | ﹤0.01% | 1315 |
|
|
2024
Q3 | $5K | Hold |
3,333
| – | – | ﹤0.01% | 1055 |
|
|
2024
Q2 | $2.34K | Hold |
3,333
| – | – | ﹤0.01% | 1144 |
|
|
2024
Q1 | $3.17K | Hold |
3,333
| – | – | ﹤0.01% | 1073 |
|
|
2023
Q4 | $3.7K | Hold |
3,333
| – | – | ﹤0.01% | 1025 |
|
|
2023
Q3 | $6.27K | Hold |
3,333
| – | – | ﹤0.01% | 860 |
|
|
2023
Q2 | $12K | Hold |
3,333
| – | – | ﹤0.01% | 696 |
|
|
2023
Q1 | $11.2K | Hold |
3,333
| – | – | ﹤0.01% | 702 |
|
|
2022
Q4 | $5.17K | Hold |
3,333
| – | – | ﹤0.01% | 908 |
|
|
2022
Q3 | $5K | Hold |
3,333
| – | – | ﹤0.01% | 916 |
|
|
2022
Q2 | $7K | Hold |
3,333
| – | – | ﹤0.01% | 717 |
|
|
2022
Q1 | $11K | Hold |
3,333
| – | – | ﹤0.01% | 610 |
|
|
2021
Q4 | $14K | Hold |
3,333
| – | – | ﹤0.01% | 557 |
|
|
2021
Q3 | $27K | Hold |
3,333
| – | – | 0.01% | 432 |
|
|
2021
Q2 | $25K | Hold |
3,333
| – | – | 0.01% | 418 |
|
|
2021
Q1 | $28K | Hold |
3,333
| – | – | 0.01% | 370 |
|
|
2020
Q4 | $26K | Hold |
3,333
| – | – | 0.01% | 350 |
|
|
2020
Q3 | $26K | Buy |
+3,333
| New | +$26K | 0.01% | 322 |
|